Endogenous Parathyroid Hormone Promotes Fracture Healing by Increasing Expression of BMPR2 through cAMP/PKA/CREB Pathway in Mice

Cell Physiol Biochem. 2017;42(2):551-563. doi: 10.1159/000477605. Epub 2017 Jun 5.

Abstract

Background/aims: Endogenous parathyroid hormone (PTH) plays an important role in fracture healing. This study investigated whether endogenous PTH regulates fracture healing by bone morphogenetic protein (BMP) and/or the transforming growth factor-β (TGF-β) signaling pathway.

Methods: Eight-week-old wild-type (WT) and PTH-knockout (PTH KO) male mice were selected, and models of open right-femoral fracture were constructed. Fracture healing and callus characteristics of mice in the two groups were compared by X-ray, micro-computed tomography, histological, and immunohistochemical examinations. Bone marrow mesenchymal stem cells (BMMSCs) of 8-week-old WT and PTHKO male mice were obtained and induced into osteoblasts and chondrocytes.

Results: We found that expression levels of Runt-related transcription factor (RUNX2), bone morphogenetic protein-receptor-type Ⅱ (BMPR2), phosphorylated Smad 1/5/8, and phosphorylated cyclic adenosine monophosphate-responsive element binding protein (CREB) in the callus of PTHKO mice were significantly decreased, whereas no significant difference in expression of SOX9, TGF-βR2,or pSMAD2/3 was observed between PTHKO and WT mice. Additionally, the activity of osteoblast alkaline phosphatase was low at 7 days post-induction, and was upregulated by addition of PTH or dibutyryl cyclic adenosine monophosphate (dbcAMP) to the cell culture. Furthermore, H89 (protein kinase A inhibitor)eliminated the simulating effects of PTH and dbcAMP, and a low concentration of cyclic adenosine monophosphate (cAMP) was observed in PTHKO mouse BMMSCs.

Conclusion: These results suggested that endogenous PTH enhanced BMPR2 expression by a cAMP/PKA/CREB pathway in osteoblasts, and increased RUNX2 expression through transduction of the BMP/pSMAD1/5/8 signaling pathway.

Keywords: BMPR2; Fracture healing; PTH; cAMP/PKA/CREB.

MeSH terms

  • Alkaline Phosphatase / antagonists & inhibitors
  • Alkaline Phosphatase / genetics
  • Animals
  • Bone Morphogenetic Protein Receptors, Type II / biosynthesis*
  • Bone Morphogenetic Protein Receptors, Type II / genetics
  • Cyclic AMP Response Element-Binding Protein / genetics
  • Cyclic AMP-Dependent Protein Kinases / genetics
  • Fracture Healing / genetics*
  • Fractures, Open / genetics*
  • Fractures, Open / pathology
  • Fractures, Open / therapy
  • Gene Expression Regulation / drug effects
  • Humans
  • Isoquinolines / administration & dosage
  • Mice
  • Mice, Knockout
  • Osteoblasts
  • Parathyroid Hormone / biosynthesis
  • Parathyroid Hormone / genetics*
  • Signal Transduction / genetics
  • Smad Proteins / genetics
  • Sulfonamides / administration & dosage

Substances

  • Creb1 protein, mouse
  • Cyclic AMP Response Element-Binding Protein
  • Isoquinolines
  • Parathyroid Hormone
  • Smad Proteins
  • Sulfonamides
  • Cyclic AMP-Dependent Protein Kinases
  • Bmpr2 protein, mouse
  • Bone Morphogenetic Protein Receptors, Type II
  • Alkaline Phosphatase
  • N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide